Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6.89M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
848K
-
Shares change
-
+848K
-
Total reported value, excl. options
-
$3.77M
-
Value change
-
+$3.77M
-
Number of buys
-
15
-
Price
-
$4.44
Significant Holders of Aprea Therapeutics, Inc. - Common Stock (APRE) as of Q1 2023
16 filings reported holding APRE - Aprea Therapeutics, Inc. - Common Stock as of Q1 2023.
Aprea Therapeutics, Inc. - Common Stock (APRE) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 848K shares
of 6.89M outstanding shares and own 12.32% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (345K shares), Sio Capital Management, LLC (280K shares), Walleye Capital LLC (93.3K shares), Worth Venture Partners, LLC (84.9K shares), VANGUARD GROUP INC (15.5K shares), MORGAN STANLEY (14.6K shares), BlackRock Inc. (9.24K shares), GROUP ONE TRADING, L.P. (2.16K shares), Tower Research Capital LLC (TRC) (1.48K shares), and PNC Financial Services Group, Inc. (1K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.